Literature DB >> 10347796

Differential effects of isoproterenol on the activity of angiotensin-converting enzyme in the rat heart and aorta.

V C Busatto1, V Cunha, M A Cicilini, J G Mill.   

Abstract

The excessive stimulation of beta-adrenergic receptors in the heart induces myocardial hypertrophy. There are several experimental data suggesting that this hypertrophy may also depend, at least partially, on the increase of local production of angiotensin II secondary to the activation of the cardiac renin-angiotensin system. In this study we investigated the effects of isoproterenol on the activity of angiotensin-converting enzyme (ACE) in the heart and also in the aorta and plasma. Male Wistar rats weighing 250 to 305 g were treated with a dose of (+/-)-isoproterenol (0.3 mg kg-1 day-1, N = 8) sufficient to produce cardiac hypertrophy without deleterious effects on the pumping capacity of the heart. Control rats (N = 7) were treated with vehicle (corn oil). The animals were killed one week later. ACE activity was determined in vitro in the four cardiac chambers, aorta and plasma by a fluorimetric assay. A significant hypertrophy was observed in both ventricular chambers. ACE activity in the atria remained constant after isoproterenol treatment. There was a significant increase (P < 0.05) of ACE activity in the right ventricle (6.9 +/- 0.9 to 8.2 +/- 0.6 nmol His-Leu g-1 min-1) and in the left ventricle (6.4 +/- 1.1 to 8.9 +/- 0.8 nmol His-Leu g-1 min-1). In the aorta, however, ACE activity decreased (P < 0.01) after isoproterenol (41 +/- 3 to 27 +/- 2 nmol His-Leu g-1 min-1) while it remained unchanged in the plasma. These data suggest that ACE expression in the heart can be increased by stimulation of beta-adrenoceptors. However, this effect is not observed on other local renin-angiotensin systems, such as the aorta. Our data also suggest that the increased sympathetic discharge and the elevated plasma concentration of catecholamines may contribute to the upregulation of ACE expression in the heart after myocardial infarction and heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347796     DOI: 10.1590/s0100-879x1999000300017

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  3 in total

1.  Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; Jessica L Voncannon; Norihito Moniwa; Stephen W Simington; Bridget K Brosnihan; Patricia E Gallagher; Javad Habibi; James R Sowers; Carlos M Ferrario
Journal:  J Hypertens       Date:  2012-09       Impact factor: 4.844

2.  Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation.

Authors:  Ana Paula C Davel; Elisa Mitiko Kawamoto; Cristoforo Scavone; Dalton V Vassallo; Luciana V Rossoni
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

Review 3.  A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.

Authors:  Jihong Yang; Yufeng Liu; Xiaohui Fan; Zheng Li; Yiyu Cheng
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.